Background - Toll-like receptor 4 (Tlr4) is the receptor for exogenous lipopolysaccharides (LPS). Expression of endogenous Tlr4 ligands, heat shock protein 60 (Hsp60) and extra domain A of fibronectin, has been observed in arthritic and oncological specimens in which matrix turnover is an important feature. In atherosclerosis, outward remodeling is characterized by matrix turnover and a structural change in arterial circumference and is associated with a vulnerable plaque phenotype. Since Tlr4 ligands are expressed during matrix turnover, we hypothesized that Tlr4 is involved in arterial remodeling.Methods and Results - In a femoral artery cuff model in the atherosclerotic ApoE3 ( Leiden) transgenic mouse, Tlr4 activation by LPS stimulated ...
Toll-like receptor 4 (TLR4) is a pattern recognition receptor for lipopolysaccharide from Gram negat...
OBJECTIVE The role of toll-like receptors (TLRs) in vascular remodeling is well established. However...
Focused Conference Group: P09 – Nflammation and Immunopharmacology: New Tools for Old Diseases. Pape...
Background - Toll-like receptor 4 (Tlr4) is the receptor for exogenous lipopolysaccharides (LPS). Ex...
Atherosclerosis and arterial remodeling Atherosclerosis is a chronic inflammatory disease and the pr...
International audienceThe critical role of Toll-like receptors (TLRs) in mammalian host defense has ...
Background: Toll like receptors (TLR) have been recognized for their role in atherosclerotic lesion ...
Objective-The goal of this study was to explore the role of Toll-like receptor 4 (TLR4) in vein graf...
The immune system plays a pivotal role in initiation and progression of atherosclerosis. Monocytes a...
Objective—Atherosclerosis encompasses a conspicuously maladaptive inflammatory response that might i...
Atherosclerosis begins in the vessel wall with the retention of low density lipoproteins to modified...
[[abstract]]AIMS: Disturbed blood flow at arterial branches and curvatures modulates endothelial fun...
Background: RP105 (CD180) is TLR4 homologue lacking the intracellular TLR4 signaling domain and acts...
Oxidized low-density lipoprotein (oxLDL)-regulated secretion of inflammatory cytokines in smooth mus...
International audienceObjective. To assess the role of Toll-like receptors (TLRs) in antiphospholipi...
Toll-like receptor 4 (TLR4) is a pattern recognition receptor for lipopolysaccharide from Gram negat...
OBJECTIVE The role of toll-like receptors (TLRs) in vascular remodeling is well established. However...
Focused Conference Group: P09 – Nflammation and Immunopharmacology: New Tools for Old Diseases. Pape...
Background - Toll-like receptor 4 (Tlr4) is the receptor for exogenous lipopolysaccharides (LPS). Ex...
Atherosclerosis and arterial remodeling Atherosclerosis is a chronic inflammatory disease and the pr...
International audienceThe critical role of Toll-like receptors (TLRs) in mammalian host defense has ...
Background: Toll like receptors (TLR) have been recognized for their role in atherosclerotic lesion ...
Objective-The goal of this study was to explore the role of Toll-like receptor 4 (TLR4) in vein graf...
The immune system plays a pivotal role in initiation and progression of atherosclerosis. Monocytes a...
Objective—Atherosclerosis encompasses a conspicuously maladaptive inflammatory response that might i...
Atherosclerosis begins in the vessel wall with the retention of low density lipoproteins to modified...
[[abstract]]AIMS: Disturbed blood flow at arterial branches and curvatures modulates endothelial fun...
Background: RP105 (CD180) is TLR4 homologue lacking the intracellular TLR4 signaling domain and acts...
Oxidized low-density lipoprotein (oxLDL)-regulated secretion of inflammatory cytokines in smooth mus...
International audienceObjective. To assess the role of Toll-like receptors (TLRs) in antiphospholipi...
Toll-like receptor 4 (TLR4) is a pattern recognition receptor for lipopolysaccharide from Gram negat...
OBJECTIVE The role of toll-like receptors (TLRs) in vascular remodeling is well established. However...
Focused Conference Group: P09 – Nflammation and Immunopharmacology: New Tools for Old Diseases. Pape...